Literature DB >> 8955450

Etiology and pathogenesis of attention-deficit hyperactivity disorder (ADHD): significance of prematurity and perinatal hypoxic-haemodynamic encephalopathy.

H C Lou1.   

Abstract

Attention-deficit Hyperactivity Disorder (ADHD), defined as a disorder of awareness with impulsivity, has lately been characterized as a dysfunction of the striatum (neostriatum = globus pallidus + putamen). This structure is in a unique position of contextual analysis and samples information samples information from almost the entire cortex through its spiny neurons. The etiology is heterogeneous, with genetic as well as lesional factors. Among the latter, pre- and perinatal events are prominent. Advances in the understanding of the role of fetal circulatory insufficiency with loss of autoregulation and systemic hypotension have drawn attention to the vulnerability of watershed regions, including the striatum. Not only circulatory facts are important for this selectivity, however. The anatomical characteristics, with convergent glutaminergic afferent synaptic transmission from almost the entire cortex contribute to the vulnerability in ischemia-induced liberation of glutamate: The striatum becomes the victim of its virtue. Repeated hypoxic-ischemic events are particularly common in prematurity, a fact which seems to explain the high incidence of ADHD in this patient group. The magnitude, of the problem is increasing with the increased survival rate among premature infants.

Entities:  

Mesh:

Year:  1996        PMID: 8955450     DOI: 10.1111/j.1651-2227.1996.tb13909.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  44 in total

1.  Attention deficit hyperactivity disorder.

Authors:  S M Tucker
Journal:  J R Soc Med       Date:  1999-05       Impact factor: 5.344

2.  Gray matter alterations in adults with attention-deficit/hyperactivity disorder identified by voxel based morphometry.

Authors:  Larry J Seidman; Joseph Biederman; Lichen Liang; Eve M Valera; Michael C Monuteaux; Ariel Brown; Jonathan Kaiser; Thomas Spencer; Stephen V Faraone; Nikos Makris
Journal:  Biol Psychiatry       Date:  2010-12-23       Impact factor: 13.382

Review 3.  Anatomical and functional brain imaging in adult attention-deficit/hyperactivity disorder (ADHD)--a neurological view.

Authors:  Marc Schneider; Wolfgang Retz; Andrew Coogan; Johannes Thome; Michael Rösler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-09       Impact factor: 5.270

Review 4.  Towards conceptualizing a neural systems-based anatomy of attention-deficit/hyperactivity disorder.

Authors:  Nikos Makris; Joseph Biederman; Michael C Monuteaux; Larry J Seidman
Journal:  Dev Neurosci       Date:  2009-04-17       Impact factor: 2.984

5.  Attention deficit disorder with developmental coordination disorders.

Authors:  M Landgren; B Kjellman; C Gillberg
Journal:  Arch Dis Child       Date:  1998-09       Impact factor: 3.791

Review 6.  Cardiovascular effects of medications for the treatment of attention-deficit hyperactivity disorder: what is known and how should it influence prescribing in children?

Authors:  Josephine Elia; Victoria L Vetter
Journal:  Paediatr Drugs       Date:  2010-06       Impact factor: 3.022

Review 7.  Attention deficit hyperactivity disorder--a review.

Authors:  C Williams; B Wright; I Partridge
Journal:  Br J Gen Pract       Date:  1999-07       Impact factor: 5.386

8.  Perinatal problems and psychiatric comorbidity among children with ADHD.

Authors:  Elizabeth B Owens; Stephen P Hinshaw
Journal:  J Clin Child Adolesc Psychol       Date:  2013-04-14

9.  Psychiatric symptoms and disorders in adolescents with low birth weight.

Authors:  M S Indredavik; T Vik; S Heyerdahl; S Kulseng; P Fayers; A-M Brubakk
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-09       Impact factor: 5.747

10.  Methylphenidate induces lipid and protein damage in prefrontal cortex, but not in cerebellum, striatum and hippocampus of juvenile rats.

Authors:  Felipe Schmitz; Emilene B S Scherer; Fernanda R Machado; Aline A da Cunha; Bárbara Tagliari; Carlos A Netto; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2012-09-12       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.